Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (501-510 of 611) with videos related to

Pageof 62
Sort By:
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Haematologica|April 18, 2024
Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocolAlex W K Leung, Jiaoyang Cai, Zhi Wan, et al.
The Lancet Regional Health. Western Pacific|October 4, 2023
Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control studyJiaoyang Cai, Hu Liu, Yumei Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
Annals of the American Thoracic Society|July 9, 2016
Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE)Daniel M Green, Liang Zhu, Mingjuan Wang, et al.
Blood Cancer Discovery|July 12, 2021
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapySima Jeha, John Choi, Kathryn G Roberts, et al.
The Journal of Clinical Endocrinology and Metabolism|August 3, 2019
Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health OutcomesLaura van Iersel, Zhenghong Li, Deo Kumar Srivastava, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Research Square|November 28, 2024
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemiaCharles Mullighan, Ruth Wangondu, Emily Ashcraft, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Pageof 62

Showing results (501-510 of 611) with videos related to

Sort By:
Pageof 62
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Haematologica|April 18, 2024
Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocolAlex W K Leung, Jiaoyang Cai, Zhi Wan, et al.
The Lancet Regional Health. Western Pacific|October 4, 2023
Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control studyJiaoyang Cai, Hu Liu, Yumei Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
Annals of the American Thoracic Society|July 9, 2016
Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE)Daniel M Green, Liang Zhu, Mingjuan Wang, et al.
Blood Cancer Discovery|July 12, 2021
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapySima Jeha, John Choi, Kathryn G Roberts, et al.
The Journal of Clinical Endocrinology and Metabolism|August 3, 2019
Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health OutcomesLaura van Iersel, Zhenghong Li, Deo Kumar Srivastava, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Research Square|November 28, 2024
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemiaCharles Mullighan, Ruth Wangondu, Emily Ashcraft, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Pageof 62